Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

NCT07334301

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Sydney Children's Hospital (SCH) Sydney, Australia

St. Anna Children´s Hospital Vienna, Austria

Cliniques Universitaires Saint-Luc (CUSL) Brussels, Belgium

Starship Children's Hospital (SSH) Auckland, New Zealand

View all 23 locations

View Trial Details

Recruiting

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

NCT05650749

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +18 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

NCT06803875

Conditions: High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

NCT05400603

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Recruiting

Medulloblastoma Online Video-based Exercise Pilot Study

NCT06898684

Conditions: Behavior, Glioma, Medulloblastoma, +10 more
Locations: Technical University Munich München, Germany

Queen Silvia C hildren´s Hospital Gothenburg, Sweden

View Trial Details

Recruiting

International HIT-MED Registry (I-HIT-MED)

NCT02417324

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations: University Hospital Aachen Aachen, Germany

Klinikum Augsburg Augsburg, Germany

Helios Klinikum Berlin-Buch Berlin, Germany

Charite Campus, University of Berlin Berlin, Germany

View all 57 locations

View Trial Details

Recruiting

Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma

NCT06818916

Conditions: Autologous Hematopoietic Stem Cell Transplantation, Delayed Platelet Engraftment, Neoplasms, +9 more
Locations: Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University Beijing, China

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT05770037

Conditions: Adenocarcinoma, Anaplastic Large Cell Lymphoma, Cancer, +37 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Recruiting

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

NCT06988475

Conditions: Cancer, Digestive System Diseases, Digestive System Neoplasms, +27 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

View all 17 locations

View Trial Details

Recruiting

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

NCT04081701

Conditions: Brain Diseases, Brain Neoplasms, CNS Tumors, +37 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Neuroectodermal Tumors, Primitive

Neuroectodermal Tumors, Primitive trial results

Related conditions